NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

乳房切片的全球市場預測(2020年∼2026年)

Breast Biopsy Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008106
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
乳房切片的全球市場預測(2020年∼2026年) Breast Biopsy Market 2020-2026
出版日期: 2021年05月04日內容資訊: 英文
簡介

全球乳房切片的市場規模,從2021年到2027年的預測期間內預計以8.2%的年複合成長率擴大。乳房切片,是從患部或可疑的部位切除組織的治療。然後在顯微鏡下檢查移除的細胞並進一步測試以檢查是否存在乳腺癌。推動全球乳癌市場成長的主要原因,有乳癌的高盛行率,乳癌篩檢計劃增加,微創乳癌診察的採用增加,及乳癌研究的大數量的支出等。

高額的治療,風險,及乳房切片的有害影響抑制市場。真空輔助切片檢查等新技術的引進,有前途的臨床試驗,女性的意識提高,成為市場機會。

本報告提供全球乳房切片市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最新趨勢
  • 主要的策略分析

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類型市場
    • 細微針切片檢查
    • 核心針切片檢查
    • 外科的切片檢查
    • 其他(淋巴節及真空輔助切片檢查)
  • 各產品市場
    • 切片穿刺針
    • 誘導系統
    • 切片檢查表格
    • 位置特定線
    • 化驗套件
    • 其他
  • 各指南下技術市場
    • MRI指南下切片檢查
    • 超音波指南下切片檢查
    • 乳房X光攝影指南下定位切片檢查
    • CT指南下切片檢查
    • 其他
  • 各終端用戶市場
    • 醫院
    • 診斷中心
    • 研究機關

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Co.
  • Benetec Medical Systems
  • Merit Medical Systems
  • Cigna International Corp.
  • Cook Group Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • IMS GIOTTO S.P.A.
  • Leica Biosystems Nussloch GmbH(Devicor Medical Products, Inc.)
  • Medtronic plc
  • NORAS MRI Products GmbH
  • Oncocyte Corp.
  • Planmeca Group
  • QIAGEN GmbH
  • Scion Medical Technologies, LLC.
  • Trivitron Healthcare
  • United Medical Systems Inc.
  • VigeoSRL
目錄
Product Code: OMR2023399

Global Breast Biopsy Market Size, Share & Trends Analysis Report by Type (Fine Needle Biopsy, Core Needle Biopsy, Surgical Biopsy, and Others (Lymph Node and Vacuum-Assisted Biopsy)), By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kit, and Other), By Guided Technology (MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Other), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period 2021-2027

The global breast biopsy market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2021-2027). A breast biopsy is a procedure in which tissues are removed from the affected or suspicious area. The removed cells are then examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is the only diagnostic procedure that can determine if the suspicious area is cancerous. Biopsy samples are sent to a laboratory for analysis where experts determine whether the cells are cancerous. The key factors contributing to the growth of the global breast biopsy market include the high prevalence of breast cancer, increasing breast cancer screening programs, rising adoption of minimally invasive breast biopsies, and high expenditure on breast cancer research.

Further, in Canada, as per the Canadian Cancer Society, in 2020 around 27,400 women were diagnosed with breast cancer, which was 25% new cancer cases that represent around 75 new breast cancer cases were diagnosed every day. In the US, one in eight women develops invasive breast cancer in its lifetime. Thus, the increasing number of cases has forced the government to raise awareness for the early detection of breast cancer globally. Moreover, the high cost of the procedure, risk, and harmful effects of breast biopsy are restraining the market. The introduction of new technologies such as vacuum-assisted biopsy, promising clinical trials, and raising awareness among women are some opportunities for the market.

Segmental Outlook

The global breast biopsy market is segmented based on type, product, guided technology, and end-user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy, and others. Further, others type is bifurcated into the lymph node and vacuum-assisted biopsy. The fine needle biopsy has a significant market share during the forecast period due to the rise in the demand for minimally invasive procedures, and the vacuum-assisted biopsy has significant growth during the forecast period owing to the less-invasive nature of this technique which makes a small incision through which needle is inserted. Based on the product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kit, and other. Besides, based on the guided technology, the market is segmented into MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided biopsy, CT-guided biopsy, and others. Apart from it, based on the end-user, the market is segmented into hospitals, diagnostic centers, and research institutes.

Global Breast Biopsy Market Share by Product, 2020 (%)

Source: OMR Global

Biopsy Needles holds a significant share in the Market

The biopsy needles held the major share in 2020 and are also anticipated to grow during the forecast period. The factors such as the rising adoption of image-guided procedures in emerging and developed economies, and the introduction of technologically advanced biopsy needles are driving the market growth during the forecast period. For instance, a pincer needle on the outermost edge, an outer cutting needle, and a sharp stylet on the inner side makes up the tri-axial needle. The needle design allows healthcare professionals to cut through tissue without compressing it. With the specific design of the needle, it is visible under ultrasound and CT, which are widely used for biopsy guidance.

Regional Outlooks

The global breast biopsy market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds a dominant position in the global breast biopsy market, followed by Europe. The growth is mainly due to the prevalence of breast cancer, rising adoption of minimally invasive breast biopsies significantly contributing towards the market growth in the region. For instance, as per the American Cancer Society, in 2021, it an estimated that around 281,550 new cases of invasive breast cancer are expected to be diagnosed in women in the US. Apart from it, around 49,290 new cases of non-invasive breast cancer in the US.

Global Breast Biopsy Market Growth, by Region 2021-2027

Source: OMR Global

Asia-Pacific is projected to have a considerable share in the global breast biopsy market

Asia-Pacific is anticipated to hold a considerable market share in the global breast biopsy market. This is due to increasing breast cancer screening programs. The infrastructure of healthcare in emerging economies such as China, India, and South Korea is evolving at a rapid pace, leading to major investment in advanced systems by hospitals and breast centers is driving the growth of the Asia-Pacific breast biopsy market. Apart from it, the rising prevalence of breast cancer, the rising number of awareness programs for early detection of breast cancer, and the government spending on breast cancer research are the factors that are propelling the market growth in the region. For instance, as per the Organization for Economic Corporation and Development, in 2018, around 839,000 women were diagnosed with breast cancer and more than 286,000 mortalities occurred in the region.

Market Players Outlook

The key players of the breast biopsy market include Becton, Dickson and Co., Danaher Corp., Hologic, Inc., QIAGEN GmbH, F. Hoffman-La Roche Ltd., Argon Medical Devices, Inc., Cigna International, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, geographical expansion, collaborations, and new product launches, to stay competitive in the market. For instance, in May 2019, Argon Medical Devices, Inc., a manufacturer of specialty medical devices announced that it has acquired Mana-Tech Ltd., a distributor for the UK and Ireland. This acquisition was done to expand the commercial reach of argon's products.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global breast biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Opportunity Outlook
  • COVID-19 Impact Analysis
  • Recovery Scenarios
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Breast Biopsy Market by Type
    • 5.1.1. Fine Needle Biopsy
    • 5.1.2. Core Needle Biopsy
    • 5.1.3. Surgical Biopsy
    • 5.1.4. Others (Lymph Node and Vacuum Assisted Biopsy)
  • 5.2. Global Breast Biopsy Market by Product
    • 5.2.1. Biopsy Needles
    • 5.2.2. Guidance Systems
    • 5.2.3. Biopsy Tables
    • 5.2.4. Localization Wires
    • 5.2.5. Assay Kit
    • 5.2.6. Other
  • 5.3. Global Breast Biopsy Marketby Guided Technology
    • 5.3.1. MRI-Guided Biopsy
    • 5.3.2. Ultrasound Guided Biopsy
    • 5.3.3. Mammography Guided Stereotactic Biopsy
    • 5.3.4. CT-Guided Biopsy
    • 5.3.5. Other
  • 5.4. Global Breast Biopsy Marketby End-User
    • 5.4.1. Hospitals
    • 5.4.2. Diagnostic Centre
    • 5.4.3. Research Institute

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Argon Medical Devices, Inc.
  • 7.2. Becton, Dickinson and Co.
  • 7.3. Benetec Medical Systems
  • 7.4. Merit Medical Systems
  • 7.5. Cigna International Corp.
  • 7.6. Cook Group Inc.
  • 7.7. Danaher Corp.
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Hologic, Inc.
  • 7.10. IMS GIOTTO S.P.A.
  • 7.11. Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.)
  • 7.12. Medtronic plc
  • 7.13. NORAS MRI Products GmbH
  • 7.14. Oncocyte Corp.
  • 7.15. Planmeca Group
  • 7.16. QIAGEN GmbH
  • 7.17. Scion Medical Technologies, LLC.
  • 7.18. Trivitron Healthcare
  • 7.19. United Medical Systems Inc.
  • 7.20. VigeoSRL

LIST OF TABLES

  • 1. GLOBAL BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 2. GLOBAL FINE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CORE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SURGICAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL OTHERS TYPE BIOPYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 7. GLOBAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL BIOPSY TABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL ASSAY KITFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL GUIDANCE SYSTEMSFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL LOCALIZATION WIRESFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL OTHER FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 14. GLOBAL MRI-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL CT-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 20. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL BREAST BIOPSY IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 26. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 27. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 28. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 30. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 31. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 32. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 34. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 35. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 36. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 37. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 39. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 40. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 41. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 42. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BREAST BIOPSYMARKET SHARE BY TYPE,2020 VS 2027 (%)
  • 2. GLOBAL BREAST BIOPSY MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 3. GLOBAL BREAST BIOPSY MARKET SHARE BY GUIDED TECHNOLOGY, 2020 VS 2027 (%)
  • 4. GLOBAL BREAST BIOPSYMARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 5. GLOBAL BREAST BIOPSYMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL FINE NEEDLE BIOPSYMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL CORE NEEDLE BIOPSYMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL SURGICAL BIOPSYMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL OTHERS BIOPSYMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBALBIOPSY NEEDLESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL BIOPSY TABLES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL ASSAY KIT MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL MRI-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL GUIDANCE SYSTEMSMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL LOCALIZATION WIRESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL MAMMPGRAPHY GUIDED STEROTACTIC BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL CT-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 20. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 21. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 22. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 23. GLOBAL BREAST BIOPSY IN RESAERCH INSTITUTE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 24. US BREAST BIOPSYMARKET SIZE, 2020-2027($ MILLION)
  • 25. CANADA BREAST BIOPSYMARKET SIZE, 2020-2027($ MILLION)
  • 26. UK BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. FRANCE BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 28. GERMANY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. ITALY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. SPAIN BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 31. REST OF EUROPE BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. INDIA BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 33. CHINA BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. JAPAN BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. SOUTH KOREA BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 36. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)